Compare Citius Pharmaceuticals Inc (CTXR) vs SPDR Gold Trust (GLD) Price & Performance

Citius Pharmaceuticals IncTrade

SPDR Gold TrustTrade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs SPDR Gold Trust — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while SPDR Gold Trust trades at $404.76. The key difference: SPDR Gold Trust is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

	CTXR	GLD
Market Cap	$20.01M	—
Sector	Health	—
52-Week High	$1.82	$495.90
52-Week Low	$0.48	$305.27
Enterprise Value	$16.23M	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CTXR

View details →

GLD

Citadel Securities sees strong upside for gold and silver in 2026 amid dovish Fed and rising demand.Kitco · 1 day agoBullish Gold jumps 7% on weaker dollar, lower yields, and softer US jobs data, signaling potential breakout.CNBC · 1 day agoBullish New gold ETF offers income via options, challenging traditional GLD's no-yield hold amid gold's flat run.24/7 Wall Street · 4 days agoNeutral View details →

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

About SPDR Gold Trust

GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.